Zhenzhen Wei
8 Papers
Zhenzhen Wei is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
YYFZBJS inhibits colorectal tumorigenesis by enhancing Tregs-induced immunosuppression through HIF-1α mediated hypoxia in vivo and in vitro.
Yuli Zhang,Ni Chai,Zhenzhen Wei,Zan Li,Lu Zhang,Mengjie Zhang,Junze Ren,Renjie Xu,Xiufeng Pang,Bimeng Zhang,Qing-Feng Tang,Hua Sui +11 more
TL;DR: In this article , Yi-Yi-Fu-Zi-Bai-Jiang-San (YYFZBJS) extract exerted potent anticancer activities by significantly enhancing immunosuppression in ApcMin/+ mice.
22
Akkermansia muciniphila inhibits tryptophan metabolism via the AhR/β-catenin signaling pathway to counter the progression of colorectal cancer
Lu Zhang,Qing Ji,Qiang Chen,Zhenzhen Wei,Shuochuan Liu,Long Zhang,Yuli Zhang,Zan Li,Huaimin Liu,Hua Sui +9 more
TL;DR: Benefit from supplementation with A. muciniphila protected mice from CRC development by specifically inhibiting tryptophan-mediated AhR/β-catenin signaling.
21
Hotspots and Frontiers in Inflammatory Tumor Microenvironment Research: A Scientometric and Visualization Analysis
TL;DR: The present scientometric study provides an overview of inflammatory tumor microenvironment research over the previous decades using quantitative and qualitative methods, and the findings can provide references for researchers focusing on tumor treatment.
Exosomes derived from MDR cells induce cetuximab resistance in CRC via PI3K/AKT signaling‑mediated Sox2 and PD‑L1 expression
Zhenzhen Wei,Ziyuan Wang,Qiong Chai,Zan Li,Meng-Jie Zhang,Yuli Zhang,Lu Zhang,Qing-Feng Tang,Huirong Zhu,Huan Sui +9 more
TL;DR: In this article , exosomes derived from CRC/MDR cells were found to promote cetuximab resistance in KRAS wild-type colorectal cancer (CRC) cells via activation of PI3K/AKT signaling pathway-mediated expression of Sox2 and PD-L1.
8
Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway
TL;DR: It is proved that ZJW could reverse the drug resistance of HCT116/L-OHP cells by reducing MALAT1, indirectly upregulating miR-200s, alleviating the activation of the JNK signaling axis, and downregulating the expression of resistance proteins such as MDR1/ABCB1 and ABCG2.